ArticleDigital health
MRpoxNet: An enhanced deep learning approach for early detection of monkeypox using modified ResNet50.
Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A customized MobileNetV2-based lightweight CNN for monkeypox detection and classification.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To develop an enhanced deep learning model, MRpoxNet, based on a modified ResNet50 architecture for the early detection of monkeypox from digital skin lesion images, ensuring high diagnostic accuracy and clinical reliability. Methods: The study utilized the Kaggle MSID dataset, initially comprising 1156 images, augmented to 6116 images across three classes: monkeypox, non-monkeypox, and normal skin. MRpoxNet was developed by extending ResNet50 from 177 to 182 layers, incorporating additional convolutional, ReLU, dropout, and batch normalization layers. Performance was evaluated using metrics such as accuracy, precision, recall, F1 score, sensitivity, and specificity. Comparative analyses were conducted against established models like ResNet50, AlexNet, VGG16, and GoogleNet. Results: MRpoxNet achieved a diagnostic accuracy of 98.1%, outperforming baseline models in all key metrics. The enhanced architecture demonstrated superior robustness in distinguishing monkeypox lesions from other skin conditions, highlighting its potential for reliable clinical application. Conclusion: MRpoxNet provides a robust and efficient solution for early monkeypox detection. Its superior performance suggests readiness for integration into diagnostic workflows, with future enhancements aimed at dataset expansion and multimodal adaptability to diverse clinical scenarios.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.